Nifty

:

23382.60

Sensex

:

74267.34

-165.15 (-0.70%)
-508.40 (-0.68%)

Login

Nifty
Sensex

:
:

23382.60
74267.34

-165.15 (-0.70%)
-508.40 (-0.68%)

Healthcare Global Enterprises Ltd.

Hospital & Healthcare Services

Rating :

63/99

BSE: 539787 | NSE: HCG

Watchlist

NSE BSE

646.15

01-Jun-2026

Open
High
Low
Previous Close

643.8
649.25
631.25
637.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

69586
44784760.15
799.71
513.3

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9,676.28
703.22
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,769.22
N/A
7.26

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.27
17.06
9.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.27
25.62
6.42

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
14.80

P:E (Median)

8 Years
5 Years
3 Years

59.35
125.68
147.58

P:BV (Average)

8 Years
5 Years
3 Years

4.92
6.19
7.46

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.94
18.13
18.52

Earnings Forecasts:

(Updated: 30-05-2026)

Description 2024 2025 2026 2027
Adj EPS 3.9 9.49 14.97
P/E Ratio 165.68 68.09 43.16
Revenue 2561.2 2915.52 3332.89 3960.95
EBITDA 464.9 572.57 687.17 833.95
Net Income 40.34 139.83 223.56 355.9
ROA
P/B Ratio 9.11 8.11 5.94 4.71
ROE 4.82 9.26 13.23 15.5
FCFF 223.45 261.35 294.92 394.8
FCFF Yield 2.02 2.36 2.67 3.57
Net Debt
BVPS 70.9 79.72 108.81 137.3

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 350.21 324.38 7.96% 342.16 312.51 9.49% 345.84 329.25 5.04% 327.09 314.35 4.05%
Expenses 275.07 265.49 3.61% 287.86 270.19 6.54% 283.54 267.67 5.93% 277.24 261.82 5.89%
EBITDA 75.14 58.89 27.59% 54.30 42.32 28.31% 62.30 61.58 1.17% 49.85 52.53 -5.10%
EBIDTM 21.46% 18.15% 15.87% 13.54% 18.01% 18.70% 15.24% 16.71%
Other Income 14.92 9.46 57.72% 2.99 5.29 -43.48% 3.82 9.79 -60.98% 7.94 10.07 -21.15%
Interest 20.19 22.50 -10.27% 20.61 21.27 -3.10% 21.36 20.58 3.79% 24.30 19.79 22.79%
Depreciation 31.30 29.05 7.75% 30.09 27.90 7.85% 30.16 27.88 8.18% 28.25 26.56 6.36%
PBT -8.95 16.80 - -1.27 -36.38 - 14.60 22.91 -36.27% 5.24 16.25 -67.75%
Tax -10.48 6.65 - -0.09 0.95 - 3.82 4.96 -22.98% 1.79 3.49 -48.71%
PAT 1.53 10.15 -84.93% -1.18 -37.33 - 10.78 17.95 -39.94% 3.45 12.76 -72.96%
PATM 0.44% 3.13% -0.34% -11.95% 3.12% 5.45% 1.05% 4.06%
EPS 0.10 0.68 -85.29% -0.08 -2.50 - 0.72 1.20 -40.00% 0.23 0.85 -72.94%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 652.33 585.16 11.48% 633.07 558.57 13.34% 646.85 553.54 16.86% 613.16 525.58 16.66%
Expenses 527.25 479.44 9.97% 523.46 470.19 11.33% 523.54 451.27 16.01% 505.37 434.67 16.27%
EBITDA 125.08 105.72 18.31% 109.61 88.38 24.02% 123.31 102.27 20.57% 107.79 90.91 18.57%
EBIDTM 19.17% 18.07% 17.31% 15.82% 19.06% 18.48% 17.58% 17.30%
Other Income 13.07 10.23 27.76% 2.47 4.64 -46.77% 2.62 11.13 -76.46% 6.83 8.81 -22.47%
Interest 42.70 44.17 -3.33% 44.78 40.70 10.02% 43.62 35.98 21.23% 45.47 33.71 34.89%
Depreciation 62.81 58.07 8.16% 60.65 56.52 7.31% 62.80 49.74 26.26% 57.91 47.01 23.19%
PBT 0.73 13.71 -94.68% -6.02 -4.20 - 19.51 27.68 -29.52% 11.24 19.00 -40.84%
Tax -2.79 6.85 - 1.83 -11.05 - -0.84 6.97 - 5.94 5.36 10.82%
PAT 3.52 6.86 -48.69% -7.85 6.85 - 20.35 20.71 -1.74% 5.30 13.64 -61.14%
PATM 0.54% 1.17% -1.24% 1.23% 3.15% 3.74% 0.86% 2.60%
EPS 0.15 0.52 -71.15% -0.66 0.50 - 1.15 1.28 -10.16% 0.34 0.86 -60.47%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,365.30 1,276.52 1,170.66 1,005.57 849.83 608.86 688.33 640.50 586.27 545.03 471.13 Net Sales Growth 6.62% 9.04% 16.42% 18.33% 39.58% -11.55% 7.47% 9.25% 7.57% 15.69% Cost Of Goods Sold 353.16 317.65 281.50 236.28 210.32 138.46 146.57 153.31 155.15 149.39 133.56 Gross Profit 1,012.14 958.87 889.16 769.29 639.51 470.40 541.76 487.19 431.11 395.64 337.58 GP Margin 74.13% 75.12% 75.95% 76.50% 75.25% 77.26% 78.71% 76.06% 73.53% 72.59% 71.65% Total Expenditure 1,123.71 1,065.17 970.07 836.51 702.96 535.40 572.61 546.43 504.48 462.36 407.34 Power & Fuel Cost - 21.17 21.09 18.82 19.76 18.50 19.56 16.34 14.51 13.29 12.06 % Of Sales - 1.66% 1.80% 1.87% 2.33% 3.04% 2.84% 2.55% 2.47% 2.44% 2.56% Employee Cost - 220.58 205.18 175.03 156.63 136.72 142.69 130.32 115.58 98.06 84.69 % Of Sales - 17.28% 17.53% 17.41% 18.43% 22.46% 20.73% 20.35% 19.71% 17.99% 17.98% Manufacturing Exp. - 328.92 291.33 253.79 221.52 177.19 195.25 175.89 144.45 145.09 128.69 % Of Sales - 25.77% 24.89% 25.24% 26.07% 29.10% 28.37% 27.46% 24.64% 26.62% 27.32% General & Admin Exp. - 152.67 146.52 115.10 76.97 53.57 53.85 61.53 60.64 50.89 42.58 % Of Sales - 11.96% 12.52% 11.45% 9.06% 8.80% 7.82% 9.61% 10.34% 9.34% 9.04% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 24.17 24.45 37.48 17.75 10.95 14.68 9.05 14.14 5.63 0.00 % Of Sales - 1.89% 2.09% 3.73% 2.09% 1.80% 2.13% 1.41% 2.41% 1.03% 1.22% EBITDA 241.59 211.35 200.59 169.06 146.87 73.46 115.72 94.07 81.79 82.67 63.79 EBITDA Margin 17.70% 16.56% 17.13% 16.81% 17.28% 12.07% 16.81% 14.69% 13.95% 15.17% 13.54% Other Income 29.67 38.58 16.20 22.02 12.42 24.02 12.11 13.48 22.87 6.72 3.38 Interest 86.46 84.14 50.07 41.49 42.80 62.86 82.99 47.81 26.80 15.93 34.44 Depreciation 119.80 111.39 96.92 88.97 88.36 86.58 79.41 47.17 43.92 44.16 36.91 PBT 9.62 54.40 69.80 60.62 28.13 -51.96 -34.57 12.56 33.94 29.30 -4.17 Tax -4.96 16.05 20.90 17.43 42.79 -13.51 -12.16 5.32 11.98 9.82 -3.91 Tax Rate -51.56% 81.97% 38.91% 30.25% 52.80% 6.59% 18.58% 42.36% 32.48% 33.52% 45.25% PAT 14.58 3.53 32.80 40.19 38.25 -191.55 -53.30 7.25 24.89 19.48 -4.73 PAT before Minority Interest 14.58 3.53 32.80 40.19 38.25 -191.55 -53.30 7.25 24.89 19.48 -4.73 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.07% 0.28% 2.80% 4.00% 4.50% -31.46% -7.74% 1.13% 4.25% 3.57% -1.00% PAT Growth 313.03% -89.24% -18.39% 5.07% - - - -70.87% 27.77% - EPS 0.98 0.24 2.20 2.69 2.56 -12.83 -3.57 0.49 1.67 1.30 -0.32

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,545.41 2,218.14 1,907.87 1,691.41 1,394.78 1,009.18 1,092.34 976.03 828.79 700.11 584.17 Net Sales Growth 14.51% 16.26% 12.80% 21.27% 38.21% -7.61% 11.92% 17.77% 18.38% 19.85% Cost Of Goods Sold 692.30 580.60 475.42 424.07 354.91 240.31 239.86 218.64 189.72 170.91 150.02 Gross Profit 1,853.11 1,637.54 1,432.45 1,267.35 1,039.88 768.87 852.48 757.39 639.07 529.20 434.15 GP Margin 72.80% 73.82% 75.08% 74.93% 74.56% 76.19% 78.04% 77.60% 77.11% 75.59% 74.32% Total Expenditure 2,079.62 1,835.57 1,582.53 1,411.17 1,159.81 886.86 923.46 853.48 716.44 595.12 499.41 Power & Fuel Cost - 43.97 39.35 36.89 34.54 31.75 33.26 28.82 22.89 16.42 14.35 % Of Sales - 1.98% 2.06% 2.18% 2.48% 3.15% 3.04% 2.95% 2.76% 2.35% 2.46% Employee Cost - 353.48 308.24 275.12 233.65 195.94 208.03 184.52 157.71 121.92 100.53 % Of Sales - 15.94% 16.16% 16.27% 16.75% 19.42% 19.04% 18.91% 19.03% 17.41% 17.21% Manufacturing Exp. - 598.62 520.39 456.89 391.27 316.75 337.65 291.94 229.97 203.61 169.26 % Of Sales - 26.99% 27.28% 27.01% 28.05% 31.39% 30.91% 29.91% 27.75% 29.08% 28.97% General & Admin Exp. - 225.11 204.67 176.67 118.64 85.52 88.17 116.78 99.18 74.46 57.79 % Of Sales - 10.15% 10.73% 10.45% 8.51% 8.47% 8.07% 11.96% 11.97% 10.64% 9.89% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 33.80 34.47 41.54 26.82 16.58 16.48 12.79 16.99 7.78 0.00 % Of Sales - 1.52% 1.81% 2.46% 1.92% 1.64% 1.51% 1.31% 2.05% 1.11% 1.28% EBITDA 465.79 382.57 325.34 280.24 234.97 122.32 168.88 122.55 112.35 104.99 84.76 EBITDA Margin 18.30% 17.25% 17.05% 16.57% 16.85% 12.12% 15.46% 12.56% 13.56% 15.00% 14.51% Other Income 24.99 39.53 21.19 31.63 15.67 21.20 10.27 10.06 19.28 9.67 3.99 Interest 176.57 154.56 108.74 103.50 97.77 119.17 137.65 69.91 42.35 23.00 38.33 Depreciation 244.17 211.34 174.36 163.47 158.28 159.22 148.44 85.08 71.46 56.83 44.08 PBT 25.46 56.19 63.44 44.90 -5.41 -134.85 -106.94 -22.39 17.81 34.84 6.34 Tax 4.14 8.13 26.39 27.25 48.85 -7.56 6.19 -2.50 10.24 11.80 -1.97 Tax Rate 16.26% 14.47% 39.19% 60.69% 54.76% 3.31% -5.79% 11.17% 35.83% 33.87% -729.63% PAT 21.32 44.41 48.15 29.35 53.73 -193.46 -106.69 -24.80 20.53 22.17 -1.46 PAT before Minority Interest 12.30 48.83 41.33 17.63 38.92 -221.10 -125.45 -30.88 16.94 23.04 2.24 Minority Interest -9.02 -4.42 6.82 11.72 14.81 27.64 18.76 6.08 3.59 -0.87 -3.70 PAT Margin 0.84% 2.00% 2.52% 1.74% 3.85% -19.17% -9.77% -2.54% 2.48% 3.17% -0.25% PAT Growth -55.64% -7.77% 64.05% -45.38% - - - - -7.40% - EPS 1.43 2.97 3.23 1.97 3.60 -12.96 -7.15 -1.66 1.38 1.48 -0.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,191.32 1,181.47 1,145.12 1,097.69 923.78 614.51 644.72 638.44 545.19 519.97 Share Capital 139.42 139.29 139.12 139.01 125.36 88.69 87.92 86.90 85.71 85.08 Total Reserves 1,029.55 1,024.63 993.98 951.96 747.82 518.76 551.23 517.85 458.26 433.99 Non-Current Liabilities 789.64 643.53 363.79 330.77 373.47 662.47 389.06 244.00 116.66 113.20 Secured Loans 290.29 258.76 105.02 80.39 124.77 281.70 232.09 137.21 45.97 19.48 Unsecured Loans 13.28 15.15 7.70 1.64 22.36 33.25 114.06 80.04 77.61 103.31 Long Term Provisions 12.40 11.41 9.50 7.79 6.29 5.37 4.39 3.73 2.44 2.32 Current Liabilities 622.84 414.11 220.80 215.08 249.93 476.64 366.65 220.72 248.63 202.39 Trade Payables 152.17 147.94 109.00 96.33 81.29 99.14 106.34 114.42 105.37 97.28 Other Current Liabilities 172.21 147.51 95.56 104.00 92.97 265.97 204.27 99.36 97.46 64.68 Short Term Borrowings 279.78 101.42 0.00 0.63 67.02 103.99 49.99 1.74 41.27 36.88 Short Term Provisions 18.68 17.24 16.23 14.12 8.65 7.54 6.05 5.20 4.54 3.54 Total Liabilities 2,603.80 2,239.11 1,729.71 1,643.54 1,547.18 1,753.62 1,400.43 1,103.16 910.48 835.56 Net Block 1,038.05 974.10 787.63 773.84 745.17 914.33 546.79 492.00 442.12 431.07 Gross Block 1,698.88 1,565.96 1,274.55 1,176.63 1,058.23 1,140.86 692.70 590.81 510.82 467.05 Accumulated Depreciation 660.84 591.86 486.92 402.79 313.06 226.52 145.92 98.81 68.70 35.98 Non Current Assets 1,963.35 1,707.42 1,357.19 1,287.39 1,219.19 1,513.03 1,169.83 905.53 682.45 618.40 Capital Work in Progress 22.61 36.49 9.22 4.82 27.61 43.61 104.11 79.11 33.41 28.57 Non Current Investment 695.75 506.32 474.93 438.66 365.66 316.13 299.04 218.84 133.93 94.67 Long Term Loans & Adv. 148.25 133.41 77.77 63.13 73.58 148.46 122.73 91.83 53.18 49.86 Other Non Current Assets 58.69 57.10 7.64 6.95 7.19 90.50 97.16 23.74 19.80 14.23 Current Assets 640.45 531.69 372.52 356.16 327.99 240.58 230.61 197.64 228.03 217.15 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.49 60.02 Inventories 19.76 23.22 21.22 17.30 11.95 12.51 16.34 17.10 14.90 11.08 Sundry Debtors 261.98 220.68 212.37 160.25 147.48 152.32 145.60 126.21 100.60 69.16 Cash & Bank 264.14 237.33 80.36 119.96 14.46 15.14 8.54 15.31 74.58 50.46 Other Current Assets 94.57 15.83 14.43 13.62 154.10 60.61 60.13 39.01 30.46 26.41 Short Term Loans & Adv. 77.68 34.63 44.13 45.03 140.09 48.63 48.73 32.52 26.56 22.10 Net Current Assets 17.61 117.58 151.72 141.07 78.06 -236.06 -136.05 -23.08 -20.60 14.76 Total Assets 2,603.80 2,239.11 1,729.71 1,643.55 1,547.18 1,753.61 1,400.44 1,103.17 910.48 835.55

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 922.44 825.78 860.52 870.29 697.18 381.25 476.65 515.10 432.66 425.82 Share Capital 139.42 139.29 139.12 139.01 125.36 88.69 87.92 86.90 85.71 85.08 Total Reserves 760.67 668.93 709.38 724.56 521.15 285.51 383.16 394.52 345.73 339.84 Non-Current Liabilities 1,481.78 1,091.62 871.01 860.11 822.06 1,231.51 557.18 482.78 354.08 305.83 Secured Loans 587.51 466.36 340.49 348.81 323.17 482.36 376.14 224.38 136.79 80.34 Unsecured Loans 17.08 18.95 21.25 14.07 23.00 47.25 140.77 148.05 146.59 165.49 Long Term Provisions 21.43 15.66 13.19 10.51 8.62 7.28 5.64 5.10 3.05 2.90 Current Liabilities 1,046.42 743.71 570.32 469.74 465.25 575.75 547.31 358.76 365.53 262.83 Trade Payables 334.26 281.06 248.45 193.94 145.52 153.57 152.75 142.47 127.36 108.42 Other Current Liabilities 407.23 335.56 298.85 253.17 241.94 317.31 337.27 204.97 190.21 113.41 Short Term Borrowings 282.93 106.59 3.44 4.82 67.02 93.66 49.99 1.74 41.63 37.18 Short Term Provisions 21.99 20.48 19.58 17.81 10.77 11.21 7.31 9.58 6.33 3.81 Total Liabilities 3,518.25 2,700.45 2,310.74 2,213.57 2,001.31 2,227.02 1,626.69 1,420.56 1,209.73 1,027.17 Net Block 2,441.89 1,758.16 1,553.00 1,547.14 1,382.38 1,646.08 970.21 827.72 684.70 582.96 Gross Block 3,616.23 2,780.76 2,419.31 2,254.74 1,933.10 2,024.62 1,197.40 970.11 773.36 620.21 Accumulated Depreciation 1,174.34 1,022.59 866.31 707.61 550.72 378.55 227.18 142.40 88.66 37.25 Non Current Assets 2,674.45 2,020.59 1,730.41 1,711.23 1,566.34 1,923.25 1,353.72 1,200.47 965.55 799.82 Capital Work in Progress 24.76 83.18 18.18 21.73 30.01 46.09 152.63 173.97 148.23 120.86 Non Current Investment 11.31 10.32 9.69 8.82 26.28 34.12 49.05 53.17 3.95 3.63 Long Term Loans & Adv. 165.61 149.70 116.31 99.32 98.89 162.52 128.08 95.50 82.24 66.62 Other Non Current Assets 30.88 19.21 33.22 34.24 28.78 34.44 53.75 50.11 46.44 25.75 Current Assets 843.80 679.85 580.34 502.34 434.96 303.79 272.96 220.09 244.18 227.35 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.49 60.02 Inventories 53.02 42.67 38.29 29.97 21.11 23.26 26.77 24.03 18.77 13.35 Sundry Debtors 400.90 294.03 302.51 217.44 186.60 185.66 156.89 128.44 103.22 69.54 Cash & Bank 347.70 303.07 196.64 197.51 40.85 32.02 20.87 28.80 85.22 57.61 Other Current Assets 42.18 12.82 12.34 12.10 186.40 62.85 68.44 38.83 29.48 26.82 Short Term Loans & Adv. 27.93 27.26 30.56 45.31 172.57 52.08 58.50 31.80 25.05 22.77 Net Current Assets -202.62 -63.85 10.02 32.59 -30.29 -271.96 -274.35 -138.66 -121.35 -35.47 Total Assets 3,518.25 2,700.44 2,310.75 2,213.57 2,001.30 2,227.04 1,626.68 1,420.56 1,209.73 1,027.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 145.95 208.89 130.40 124.39 70.89 86.34 86.99 66.34 53.94 57.76 PBT 19.58 53.70 57.62 81.04 -205.06 -65.46 12.56 36.87 29.30 -8.64 Adjustment 226.57 173.81 150.49 79.09 284.92 191.67 90.65 60.29 56.87 74.13 Changes in Working Capital -81.64 14.49 -60.47 -21.02 -49.41 -20.00 9.90 -32.30 -25.16 -0.21 Cash after chg. in Working capital 164.51 242.00 147.64 139.12 30.45 106.21 113.11 64.86 61.01 65.28 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -18.56 -33.11 -17.25 -14.72 40.43 -19.87 -26.12 1.49 -7.06 -7.52 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -347.32 -253.94 -137.70 48.65 -245.62 -116.00 -208.29 -184.58 -72.95 -85.54 Net Fixed Assets -119.04 -318.68 -102.32 -95.61 98.63 -387.66 -126.89 -125.69 -48.61 98.60 Net Investments -189.43 -31.39 -36.27 -73.00 -49.53 -17.09 -80.20 -77.42 13.27 -70.93 Others -38.85 96.13 0.89 217.26 -294.72 288.75 -1.20 18.53 -37.61 -113.21 Cash from Financing Activity -41.55 95.92 -41.71 -41.04 235.92 -2.76 66.28 91.03 -13.86 120.05 Net Cash Inflow / Outflow -242.92 50.87 -49.02 132.00 61.19 -32.41 -55.02 -27.21 -32.87 92.26 Opening Cash & Equivalents 121.18 70.31 119.33 -12.68 -73.86 -41.45 13.58 40.81 73.67 -18.66 Closing Cash & Equivalent -121.75 121.18 70.31 119.33 -12.68 -73.86 -41.45 13.58 40.81 73.60

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.11 284.58 251.59 220.12 120.52 130.14 98.50 97.81 91.28 73.20 PBT 56.96 67.73 44.88 87.77 -228.66 -119.26 -33.38 27.18 34.84 0.27 Adjustment 368.52 291.41 275.29 166.57 361.93 298.76 166.82 101.82 74.57 85.70 Changes in Working Capital -76.50 -27.19 -45.87 -10.52 -50.71 -22.65 2.10 -26.98 -12.06 -1.91 Cash after chg. in Working capital 348.99 331.95 274.31 243.83 82.55 156.85 135.55 102.02 97.35 84.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -31.88 -47.37 -22.71 -23.70 37.97 -26.71 -37.05 -4.20 -6.07 -10.87 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -487.75 -225.73 -133.03 124.59 -171.10 -101.38 -238.20 -281.70 -209.80 -203.57 Net Fixed Assets -119.04 -318.68 -102.32 -95.61 98.63 -387.66 -126.89 -125.69 -48.61 98.60 Net Investments -189.43 -31.39 -36.27 -73.00 -49.53 -17.09 -80.20 -77.42 13.27 -70.93 Others -179.28 124.34 5.56 293.20 -220.20 303.37 -31.11 -78.59 -174.46 -231.24 Cash from Financing Activity -42.44 -64.02 -140.07 -154.88 112.24 -58.42 83.51 161.29 89.15 215.59 Net Cash Inflow / Outflow -213.08 -5.16 -21.51 189.82 61.66 -29.67 -56.18 -22.60 -29.37 85.22 Opening Cash & Equivalents 166.02 171.18 192.69 2.87 -58.79 -29.12 27.06 51.08 80.45 -4.52 Closing Cash & Equivalent -47.06 166.02 171.18 192.69 2.87 -58.79 -29.12 27.06 51.08 80.45

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 83.33 83.56 81.45 78.48 69.65 68.49 72.70 69.59 63.46 61.01 ROA 0.15% 1.65% 2.38% 2.40% -11.61% -3.38% 0.58% 2.47% 2.23% -0.62% ROE 0.30% 2.86% 3.61% 3.90% -25.87% -8.55% 1.16% 4.33% 3.67% -1.20% ROCE 6.03% 7.25% 8.02% 10.46% -12.55% 1.62% 6.13% 7.65% 6.12% 3.98% Fixed Asset Turnover 0.78 0.82 0.82 0.76 0.55 0.75 1.00 1.06 1.11 0.91 Receivable days 69.00 67.51 67.63 66.08 89.86 78.99 77.45 70.61 56.84 51.73 Inventory Days 6.14 6.93 6.99 6.28 7.33 7.65 9.53 9.96 8.70 9.32 Payable days 172.42 166.58 158.60 154.13 237.82 255.84 101.72 108.65 106.61 104.34 Cash Conversion Cycle -97.27 -92.14 -83.98 -81.76 -140.62 -169.20 -14.74 -28.08 -41.07 -43.29 Total Debt/Equity 0.56 0.36 0.11 0.10 0.27 0.80 0.66 0.44 0.40 0.37 Interest Cover 1.23 2.07 2.39 2.89 -2.26 0.21 1.26 2.38 2.84 0.75

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 64.16 58.02 60.99 62.12 51.57 42.19 53.58 55.40 50.34 49.95 ROA 1.57% 1.65% 0.78% 1.85% -10.46% -5.87% -1.31% 1.39% 2.06% 0.25% ROE 5.72% 4.99% 2.06% 5.16% -43.32% -26.77% -4.18% 4.02% 5.38% 0.64% ROCE 12.36% 12.79% 11.69% 15.17% -9.66% 2.75% 4.50% 7.75% 7.22% 5.60% Fixed Asset Turnover 0.69 0.73 0.72 0.67 0.51 0.68 0.90 0.95 1.00 0.87 Receivable days 57.18 57.06 56.10 52.87 67.32 57.23 53.35 51.01 45.03 41.66 Inventory Days 7.87 7.74 7.36 6.68 8.02 8.36 9.50 9.42 8.37 8.72 Payable days 193.42 203.27 190.39 174.56 227.13 233.06 90.28 98.06 102.64 99.93 Cash Conversion Cycle -128.37 -138.46 -126.92 -115.01 -151.79 -167.47 -27.43 -37.62 -49.23 -49.55 Total Debt/Equity 1.11 0.83 0.47 0.47 0.73 1.91 1.40 0.96 0.97 0.76 Interest Cover 1.37 1.62 1.43 1.90 -0.92 0.22 0.68 1.67 2.52 1.01

Top Investors:

nippon life india trustee ltd-a/c nippon india els

motilal oswal dynamic fund

axis mutual fund trustee limited a/c axis mutual fund

tata india pharma & healthcare fund

clarus capital i

Annual Reports:

News Update:

Healthcare Global Enterprises signs SPA to divest entire stake in BACC Health Care
20th May 2026, 13:05 PM

The company has executed the SPA on May 19, 2026
Read More
Healthcare Global Enterprises launches new cancer hospital in North Bengaluru
19th May 2026, 15:17 PM

The new facility marks a major advancement in the region’s oncology landscape, bringing together clinical excellence, compassionate care and advanced technology
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback